Effects of lifestyle changes to reduce risks of diabetes and associated cardiovascular risks: Results from large scale efficacy trials

Obesity

Volumn 17, Issue SUPPL. 3, 2009, Pages

  Horton, Edward S ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DIET; EXERCISE; HUMAN; LIFESTYLE; PHYSIOLOGY; RISK; RISK FACTOR; WEIGHT REDUCTION;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIET; EXERCISE; HUMANS; LIFE STYLE; RISK; RISK FACTORS; WEIGHT LOSS;

EID: 72449152949     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.388     Document Type: Article

References (42)

1. Diabetes Atlas Committee. Diabetes Atlas, 2nd edn. International Diabetes Federation: Brussels, 2003.
2. Harris MI. Prevalence of noninsulin-dependent diabetes and impaired glucose tolerance. In: National Diabetes Data Group (eds). Diabetes in America: Diabetes Data Compiled 1984. U.S. Department of Health and Human Services publication (PHS) 85-1468. National Institutes of Health: Bethesda, MD, 1985, V1: pp 1-31.
3. Centers for Disease Control and Prevention. Overweight and Obesity, 2009 http://www.cdc.gov/nccdphp/dnpa/obesity/index.htm. Updated 28 January 2009; cited 18 February 2009.
4. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359.
5. Cowie CC, Rust KF, Byrd-Holt DD et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health And Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-1268.
6. Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-932.
7. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003;46:3-19.
8. Buse JB, Polonsky KS, Burant CF. Type 2 diabetes mellitus. In: Larsen PR, Kronenberg HM, Melmed S, Polonsky KS (eds). Williams Textbook of Endocrinology, 10th edn, Chapter 29. Saunders: Philadelphia, 2003, pp. 1427-1483.
9. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-794
10. U.K. Prospective Diabetes Study Group. U.K. prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease. U.K. Prospective Diabetes Study Group. Diabetes 1995;44:1249-1258
11. Knowler WC, Narayan KM, Hanson RL et al. Preventing non-insulin-dependent diabetes. Diabetes 1995;44:483-488.
12. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007;30:8-13.
13. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066-3072.
14. Burchfiel CM, Sharp DS, Curb JD et al. Physical activity and incidence of diabetes: the Honolulu Heart Program. Am J Epidemiol 1995;141:360-368.
15. Helmrich S P, Ragland DR, Leung RW, Paffenbarger RS Jr. Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus. N Engl J Med 1991;325:147-152.
16. Hu FB, Leitzmann MF, Stampfer MJ et al. Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men. Arch Intern Med 2001;161:1542-1548.
17. Hu FB, Manson JE, Stampfer MJ et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345:790-797.
18. Hu FB, Sigal RJ, Rich-Edwards JW et al. Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study. JAMA 1999;282:1433-1439.
19. Lynch J, Helmrich S P, Lakka TA et al. Moderately intense physical activities and high levels of cardiorespiratory fitness reduce the risk of non-insulin-dependent diabetes mellitus in middle-aged men. Arch Intern Med 1996;156:1307-1314.
20. Manson JE, Nathan DM, Krolewski AS et al. A prospective study of exercise and incidence of diabetes among US male physicians. JAMA 1992;268:63-67.
21. Manson JE, Rimm EB, Stampfer MJ et al. Physical activity and incidence of non-insulin-dependent diabetes mellitus in women. Lancet 1991;338:774-778.
22. Wei M, Gibbons LW, Mitchell TL et al. The association between cardiorespiratory fitness and impaired fasting glucose and type 2 diabetes mellitus in men. Ann Intern Med 1999;130:89-96.
23. Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-969.
24. Colditz GA, Willett WC, Rotnitzky A, Manson JE. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 1995;122:481-486.
25. Malik VS, Willett WC, Hu FB. Sugar-sweetened beverages and BMI in children and adolescents: reanalyses of a meta-analysis. Am J Clin Nutr 2009;89:438-9; author reply 439.
26. Bazzano LA, Li TY, Joshipura KJ, Hu FB. Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care 2008;31: 1311-1317.
27. Field AE, Willett WC, Lissner L, Colditz GA. Dietary fat and weight gain among women in the Nurses' Health Study. Obesity (Silver Spring) 2007;15:967-976.
28. Pan XR, Li GW, Hu YH et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-544.
29. Tuomilehto J, Lindström J, Eriksson JG et al.; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350.
30. Laaksonen DE, Lindström J, Lakka TA et al.; Finnish diabetes prevention study. Physical activity in the prevention of type 2 diabetes: the Finnish diabetes prevention study. Diabetes 2005;54:158-165. (Pubitemid 40105108)
31. Lindström J, Ilanne-Parikka P, Peltonen M et al.; Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 2006;368:1673-1679. (Pubitemid 46048554)
32. Knowler WC, Barrett-Connor E, Fowler SE et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346: 393-403.
33. Hamman RF, Wing RR, Edelstein SL et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care 2006;29: 2102-2107.
34. Fujimoto WY, Jablonski KA, Bray GA et al.; Diabetes Prevention Program Research Group. Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes 2007;56:1680-1685.
35. Bray GA, Jablonski KA, Fujimoto WY et al.; Diabetes Prevention Program Research Group. Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr 2008;87:1212-1218.
36. Crandall J, Schade D, Ma Y et al.; Diabetes Prevention Program Research Group. The influence of age on the effects of lifestyle modification and metformin in prevention of diabetes. J Gerontol A Biol Sci Med Sci 2006;61:1075-1081.
37. Orchard TJ, Temprosa M, Goldberg R et al.; Diabetes Prevention Program Research Group. The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005;142:611-619.
38. Ratner R, Goldberg R, Haffner S et al.; Diabetes Prevention Program Research Group. Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program. Diabetes Care 2005;28:888-894.
39. Haffner S, Temprosa M, Crandall J et al.; Diabetes Prevention Program Research Group. Intensive lifestyle intervention or metformin on inflammation and coagulation in participants with impaired glucose tolerance. Diabetes 2005;54:1566-1572.
40. Bray G, Gregg E, Haffner S et al.; Look Ahead Research Group. Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study. Diab Vasc Dis Res 2006;3:202-215.
41. Pi-Sunyer X, Blackburn G, Brancati FL et al.; Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care 2007;30:1374-1383.
42. Hamdy O, Carver C. The Why WAIT program: improving clinical outcomes through weight management in type 2 diabetes. Curr Diab Rep 2008;8:413-420.